Last updated on August 2019

An Open-label Study to Evaluate the Long-term Safety of Daily Oral BCX7353 in Subjects With Type I and II Hereditary Angioedema

Brief description of study

This is an open-label study to evaluate the long term safety and effectiveness of oral treatment with BCX7353 in preventing acute angioedema attacks in patients with Type I and Type II HAE.


Clinical Study Identifier: TX227897

Find a site near you

Start Over

University of South Florida-Morsani College of Medicine

13801 Bruce B Downs Blvd. Suite 505 Tampa, FL USA
  Connect »